The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Randomized controlled trial with up to 3,000 participants at 75 sites to compare outcomes between physiological guidance by iFR data co-registered on the angiogram (interventional X-ray image) versus ...
First patient enrolled in global randomized controlled trial with up to 3,200 participants at 100 sites comparing patient outcomes after percutaneous coronary intervention (PCI) procedures guided by ...
Performing invasive physiology assessment routinely at the time of angiography reclassifies the treatment approach in a large proportion of patients with two- or three-vessel coronary disease, the ...
Angiography alone can likely determine whether revascularization is necessary in patients with severe coronary artery stenoses, but for those in whom the answer is less clear, interventionalists may ...
Please provide your email address to receive an email when new articles are posted on . Instantaneous wave-free ratio pullback may predict the physiological outcome of PCI with a high degree of ...
NEW ORLEANS, LA—Despite successful PCI and optimal angiographic outcomes, nearly one in four patients leave the catheterization lab with some degree of residual ischemia, according to the results of a ...
New data suggest that PCI guided by iFR co-registered on the angiogram can improve outcomes and reduce angina for patients more effectively than treatment guided by angiography alone Amsterdam, the ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
First patient enrolled in global randomized controlled trial with up to 3,200 participants at 100 sites comparing patient outcomes after percutaneous coronary intervention (PCI) procedures guided by ...
Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the official start of the DEFINE GPS study, with the first patient being ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results